Brian Druker, MD, Professor and Director of the OHSU Knight Cancer Institute, was quoted in a recent article on Oregon Senate Bill 316, which requires insurance companies to continue to to provide routine care to patients enrolled in clinical trials. 

Read more at the url below.

Related Links: http://www.salem-news.com/articles/june182009/patient_access_6-18-09.php